Russell Investments Group
CTIC

Russell Investments Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Russell Investments Group’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-357,303
Closed -$2.08M – 3026
2022
Q3 		$2.08M Buy
+357,303
New +$2.23M ﹤0.01% 1528
2018
Q3 		– Sell
-9,147
Closed -$46K – 3089
2018
Q2 		$46K Buy
+9,147
New +$40K ﹤0.01% 2817
2018
Q1 		– Sell
-32,318
Closed -$86K – 3117
2017
Q4 		$86K Buy
+32,318
New +$94.7K ﹤0.01% 2804

Other funds holding CTIC

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Russell Investments Group's CTIC Position: Q4 2022 in Review

Russell Investments Group sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2022, closing a stake of 357,303 shares — an estimated $2.08M sold.

Russell Investments Group first reported a position in CTIC in Q4 2017 and held it in 3 quarters. The position peaked at $2.08M in Q3 2022. 145 funds tracked by Wall St. Rank hold CTIC as of Q4 2022.

  • Russell Investments Group reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2022 after selling out during the quarter.
  • Russell Investments Group sold 357,303 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2022, an estimated $2.08M.
  • Russell Investments Group first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2017 and held it in 3 quarters.
  • Russell Investments Group's CTI BioPharma Corp. (DE) Common Stock position peaked at $2.08M in Q3 2022.
  • 145 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2022.

Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.